Endocrine Society GUIDELINES Bundle (free trial)

Hyperglycemia

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/302976

Contents of this Issue

Navigation

Page 4 of 9

Management in the Noncritical Care Setting Medical Nutrition Therapy (MNT) Î The ES recommends including MNT as a component of the glycemic management program for all hospitalized patients with diabetes and hyperglycemia. (1|⊕ ) Î The ES suggests that providing meals with a consistent amount of carbohydrate at each meal can be useful for coordinating doses of rapid- acting insulin to carbohydrate ingestion. (2|⊕ ) Glycemic Target in the Noncritical Care Setting Î The ES recommends a premeal glucose target of < 140 mg/dL (7.8 mmol/L) and a random BG of < 180 mg/dL (10.0 mmol/L) for the majority of hospitalized patients with noncritical illness. (1|⊕⊕ ) Î For avoidance of hypoglycemia, the ES suggests reassessing antidiabetic therapy when BG values fall below 5.6 mmol/L (100 mg/dL). Note: Modification of glucose-lowering treatment is usually necessary when BG values are < 3.9 mmol/L (70 mg/dL). (2|⊕ ) Î The ES suggests modifying glycemic targets according to clinical status. • For patients who are able to achieve and maintain glycemic control without hypoglycemia, a lower target range may be reasonable. • For patients with terminal illness and/or with limited life expectancy or at high risk for hypoglycemia, a higher target range (BG < 11.1 mmol/L or 200 mg/dL) may be reasonable. (2|⊕ ) Transition from Hospital to Home Î The ES suggests reinstituting the preadmission insulin regimen or oral and noninsulin injectable antidiabetic drugs at discharge for patients with acceptable preadmission glycemic control and without a contraindication to their continued use. (2|⊕ ) Î The ES suggests that the regimen the patient will be on after the transition should be started prior to discharge whenever possible. (2|⊕ ) Î The ES recommends giving patients and their family or caregivers both written and oral instructions regarding the glycemic management regimen at the time of hospital discharge. (1|⊕⊕ ) Note: These instructions need to be clearly written in a manner that is understandable to the person who will administer these medications.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Hyperglycemia